Copyright ©2014 Baishideng Publishing Group Co.
World J Orthop. Apr 18, 2014; 5(2): 134-145
Published online Apr 18, 2014. doi: 10.5312/wjo.v5.i2.134
Table 2 Effect of lipo-prostaglandin E1 on patients with neurogenic intermittent claudication in lumbar canal stenosis
AuthorYearDragDosePeriodEffective rate to NIC
Takakura[66]1986PGE140-60 μg/d14-28 consecutive days79.5% (39/49 cases)
Miura et al[67]1992Lipo-PGE110 μg/d10 d57.1% (8/14 cases)
Toribatake et al[68]1993Lipo-PGE110 μg/d10 consecutive days75.0% (12/16 cases)
Kurihara et al[69]1996Limaprost3 μg/d42 consecutive days27.3% (21/77 cases)
15 μg/d47.8% (33/69 cases)
Murakami et al[70]1997Lipo-PGE110 μg/d10 consecutive days77.5% (31/40 cases)
5 μg/d87.0% (40/46 cases)
Ono et al[71]1997Lipo-PGE110 μg/d14 consecutive days71.1% (27/38 cases)
20 μg/d76.5% (26/34 cases)
Miura et al[72]1997PGE1120 μg/d14 consecutive days33.0% (5/12 cases)
Uratuji et al[73]2003Limaprost15 μg/d42 consecutive days59.3% (54/91 cases)
Harrison et al[74]2007Limaprost15 μg/d42 consecutive days50.7% (74/146 cases)
Nakanishi et al[75]2008PGE160 μg/d14 consecutive days71.4% (45/63 cases)